TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601

PRESS RELEASE TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601 Leuven BELGIUM October 23 2017 700h CEST TiGenix NV Euronext Brussels and NASDAQ TIG an advanced biopharmaceutical company focused on exploiting the antiinflammatory p...